ITU Unit Action

TUZNUE

PRESTIGE BIOPHARMA PTE. LTD.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88106323 FILING DATE 09/06/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY MOSKOWITZ, SAMANTHA JA
L.O. ASSIGNED N90-NOT FOUND

PUB INFORMATION

RUN DATE 11/03/2020
PUB DATE 02/05/2019
STATUS 606-ABANDONED - NO STATEMENT OF USE FILED
STATUS DATE 11/02/2020
LITERAL MARK ELEMENT TUZNUE

DATE ABANDONED 11/02/2020 DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT TUZNUE
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME PRESTIGE BIOPHARMA PTE. LTD.
ADDRESS 2 Science Park Drive, #04-13 Ascent
Singapore, 118222
ENTITY 16-LTD LIAB CO
CITIZENSHIP Singapore

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Biological preparations for the treatment of cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medicinal preparations for cancer; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT Color is not claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of the literal element "TUZNUE", preceded by two sets of curved parallel lines; the first set curving down and to the right, the second set curving down and to the left.
TRANSLATION The wording "TUZNUE" has no meaning in a foreign language.

FOREIGN INFORMATION

PRIORITY CLAIMED SEC. 44(D) ON Singapore
APPLICATION NO. 40201813458P
APPLICATION FILING DATE 07/11/2018
FOREIGN REG NO. N/A
FOREIGN REG DATE N/A
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION N/A
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
11/02/2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED 027
11/02/2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED 026
03/31/2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 025
03/29/2020 EX2G S EXTENSION 2 GRANTED 024
03/29/2020 EXT2 S EXTENSION 2 FILED 023
03/29/2020 EEXT I TEAS EXTENSION RECEIVED 022
03/27/2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED 021
03/27/2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED 020
03/27/2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS 019
03/27/2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 018
03/27/2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 017
03/27/2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED 016
10/02/2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 015
09/30/2019 EX1G S EXTENSION 1 GRANTED 014
09/30/2019 EXT1 S EXTENSION 1 FILED 013
09/30/2019 EEXT I TEAS EXTENSION RECEIVED 012
04/02/2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 011
02/05/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 010
02/05/2019 PUBO A PUBLISHED FOR OPPOSITION 009
01/16/2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 008
01/03/2019 FIXD O ELECTRONIC RECORD REVIEW COMPLETE 007
12/28/2018 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED 006
12/20/2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 005
12/18/2018 DOCK D ASSIGNED TO EXAMINER 004
09/14/2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
09/13/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
09/10/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jonathan G. Morton
CORRESPONDENCE ADDRESS Jonathan G. Morton
8D Dempsey Road #03-02A
Singapore 249672 Singapore
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME PRESTIGE BIOPHARMA PTE. LTD.
ADDRESS 2 Science Park Drive, #04-13 Ascent
Singapore, 118222
ENTITY 16-LTD LIAB CO
CITIZENSHIP Singapore

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed